Observational studyCNS drugs2025
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study.
Giovanni Novi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it